Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Casey A Maguire

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing miceLisa Nieland, Anne B Vrijmoet, Isabelle W Jetten, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's DiseaseBence György, Camilla Lööv, Mikołaj P Zaborowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2017
Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAVBence György, Cyrille Sage, Artur A Indzhykulian, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Base editing as a genetic treatment for spinal muscular atrophyChristiano R R Alves, Leillani L Ha, Rebecca Yaworski, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Blood Advances|January 4, 2018
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectorsAmine Meliani, Florence Boisgerault, Zachary Fitzpatrick, et al.
Nature Biomedical Engineering|December 6, 2023
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophyChristiano R R Alves, Leillani L Ha, Rebecca Yaworski, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing miceLisa Nieland, Anne B Vrijmoet, Isabelle W Jetten, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's DiseaseBence György, Camilla Lööv, Mikołaj P Zaborowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 14, 2017
Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAVBence György, Cyrille Sage, Artur A Indzhykulian, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Base editing as a genetic treatment for spinal muscular atrophyChristiano R R Alves, Leillani L Ha, Rebecca Yaworski, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2022
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|May 15, 2024
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2Shilpa Prabhakar, Roberta L Beauchamp, Pike See Cheah, et al.
Blood Advances|January 4, 2018
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectorsAmine Meliani, Florence Boisgerault, Zachary Fitzpatrick, et al.
Nature Biomedical Engineering|December 6, 2023
Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophyChristiano R R Alves, Leillani L Ha, Rebecca Yaworski, et al.
Pageof 8